D.E. Shaw & Co’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Sell |
36,257
-470,447
| -93% | -$2.37M | ﹤0.01% | 2844 |
|
|
2025
Q1 | $3.28M | Buy |
506,704
+4,704
| +0.9% | +$30.5K | ﹤0.01% | 1570 |
|
|
2024
Q4 | $3.68M | Sell |
502,000
-428,655
| -46% | -$3.15M | ﹤0.01% | 1475 |
|
|
2024
Q3 | $6.97M | Buy |
930,655
+8,101
| +0.9% | +$60.7K | 0.01% | 1121 |
|
|
2024
Q2 | $8.21M | Buy |
922,554
+276,300
| +43% | +$2.46M | 0.01% | 996 |
|
|
2024
Q1 | $6.55M | Sell |
646,254
-122,890
| -16% | -$1.24M | 0.01% | 1138 |
|
|
2023
Q4 | $7.74M | Sell |
769,144
-111,087
| -13% | -$1.12M | 0.01% | 1001 |
|
|
2023
Q3 | $8.25M | Buy |
880,231
+826,696
| +1,544% | +$7.75M | 0.01% | 924 |
|
|
2023
Q2 | $1.31M | Sell |
53,535
-13,765
| -20% | -$338K | ﹤0.01% | 1959 |
|
|
2023
Q1 | $1.57M | Buy |
67,300
+22,305
| +50% | +$519K | ﹤0.01% | 1975 |
|
|
2022
Q4 | $1.14M | Buy |
44,995
+30,177
| +204% | +$764K | ﹤0.01% | 2350 |
|
|
2022
Q3 | $286K | Buy |
14,818
+6,230
| +73% | +$120K | ﹤0.01% | 3091 |
|
|
2022
Q2 | $219K | Sell |
8,588
-43,642
| -84% | -$1.11M | ﹤0.01% | 3362 |
|
|
2022
Q1 | $1.34M | Sell |
52,230
-92,572
| -64% | -$2.38M | ﹤0.01% | 2688 |
|
|
2021
Q4 | $6.06M | Sell |
144,802
-22,324
| -13% | -$935K | 0.01% | 1515 |
|
|
2021
Q3 | $7.27M | Sell |
167,126
-52,102
| -24% | -$2.27M | 0.01% | 1227 |
|
|
2021
Q2 | $10.4M | Buy |
219,228
+102,936
| +89% | +$4.87M | 0.01% | 1030 |
|
|
2021
Q1 | $5.96M | Buy |
116,292
+94,721
| +439% | +$4.86M | 0.01% | 1270 |
|
|
2020
Q4 | $578K | Buy |
+21,571
| New | +$578K | ﹤0.01% | 2236 |
|